(Q37091119)

18 August 2017

1 reference

title

Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease (English)

1 reference

18 August 2017

1 reference

Julie R McMullen

1

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Clinical and Experimental Pharmacology and Physiology

18 August 2017

published in

1 reference

18 August 2017

volume

35

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

349-354

1 reference

Signalling through the lipid products of phosphoinositide-3-OH kinase

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Phosphoinositide 3-kinases: a conserved family of signal transducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Size control in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Role of insulin-like growth factors in embryonic and postnatal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Role of blood pressure in cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Cardiac hypertrophy: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Regulation of cardiac hypertrophy by intracellular signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

The conserved phosphoinositide 3-kinase pathway determines heart size in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Gene therapy for cardiac cachexia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

SERCA pump level is a critical determinant of Ca(2+)homeostasis and cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Insulin regulation of heart function in aging fruit flies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Healthy Animals with Extreme Longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Extended longevity in mice lacking the insulin receptor in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Growth hormone and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

PI3K(p110alpha) inhibitors as anti-cancer agents: minding the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04873.X

10.1111/J.1440-1681.2007.04873.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference